In a statement drugmaker AstraZeneca said, a three-dose course of COVID-19 vaccine is effective against the Omicron variant of the coronavirus, citing data from an Oxford University lab study. The results of the study, which is yet to be published… Read More ›
vaccine
Booster shot appears to protect against Omicron: Moderna
In a statement Moderna Inc said, a booster dose of its COVID-19 vaccine appears to protect against the fast-spreading Omicron variant of COVID-19 in laboratory tests; its current version of the vaccine will continue to be its “first line of defense… Read More ›
France donates 501,600 doses of AstraZeneca’s COVID-19 vaccine to Nigeria
According to a senior Nigerian health official, Nigeria has received 501,600 doses of AstraZeneca’s COVID-19 vaccine from France vide a COVAX vaccine-sharing facility. In a statement, Faisal Shuaib, the head of the National Primary Health Care Development Agency said, Nigeria along… Read More ›
Oxford and AstraZeneca tweaking COVID-19 vaccines to target variants by autumn
Britain is in talks with Oxford and AstraZeneca for additional doses of their COVID-19 vaccine which has been tweaked for improved targeting of the Wuhan Coronavirus variant that was first identified in South Africa. Previously, the country had secured 100… Read More ›
Fully vaccinated Chileans can move freely within country while maintaining COVID-19 protocols
In a statement the Chilean government said, citizens who are fully vaccinated against COVID-19 will be allowed to move more freely within the country. The country has sealed its borders through mid-June in a bid to restrict fresh spikes in… Read More ›
Emergent BioSolutions Inc receives J&J’s COVID-19 vaccine order for $23M
Late of Sunday, Emergent BioSolutions Inc said, a key U.S. agency has increased an order related to the manufacturing of Johnson & Johnson’s COVID-19 vaccine, by $23 million. “The amount will be used to purchase biologics equipment specific to J&J’s… Read More ›
Pfizer Inc sells Chinese biosimilar assets to XuXi Biologics Inc
On Wednesday, in a statement Pfizer Inc said, it has decided to stop producing biosimilar products in China; it has also decided to sell one of its business unit in the eastern city of Hangzhou to WuXi Biologics Inc. “The… Read More ›
AstraZeneca sold its 7.7% stake in Moderna Inc for more than $1 billion
According to a report from The Times, AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion. Moderna’s shares soared following news of its COVID-19 vaccine breakthrough. The report did not clarify the period over… Read More ›
Israel to reopen restaurants, hotels, cafes, tourism with select countries from March
In a significant development that marks an attempt to go back to pre-coronavirus pandemic times, officials from Israel said they plan to reopen restaurants around March 9 and restart tourism with Cyprus as part of a gradual return to normality… Read More ›
MGM Resorts posts record losses, sees increasing footfalls by year end as vaccine rollout widens
MGM Resorts has posted a bigger-than-expected loss thanks to the coronavirus-induced COVID-19 pandemic which brought global travel to a standstill; it has however signaled that with increased inoculation of the COVID-19 vaccine, it is likely that demand will pick up… Read More ›